Truls Möregårdh invests in Enzymatica and enters long-term partnership with ColdZyme
Enzymatica is entering a long-term partnership with Truls Möregårdh, who is also investing in the company.
Truls was already familiar with and used ColdZyme. Through the investment and partnership, he is now taking that engagement a step further, from product user to investor in the company behind the technology.
The partnership comes at an exciting stage for Enzymatica as the company continues its efforts to bring ColdZyme to more international consumer markets. This autumn, Truls will also feature in the new “Vänta inte” (“Don’t Wait”) consumer campaign.
The collaboration combines a long-term partnership with a personal commitment to both ColdZyme and Enzymatica’s continued development.
Read the full press release here: Truls Möregårdh enters long-term partnetship with ColdZyme